PRRT2 and B-cell chronic lymphocytic leukemia: Assessment of expression levels demonstrated that PKCβII is the dominant PKC isoform expressed in CLL cells, and PKCβII is routinely present in the active form compared with normal B-cells, with membrane-association correlating with its activity.